Why is Aarti Drugs falling/rising?

As of 24-Jun, Aarti Drugs Ltd's stock price is currently at 437.40, reflecting an increase of 4.9, or 1.13%. Today, the stock opened with a gain of 3.34% and reached an intraday high of Rs 446.95. Despite this positive movement, the stock has underperformed in the short term, with a 1-week return of -2.80% and a 1-month return of -8.00%. The company has shown strong financial metrics, including a high return on capital employed (ROCE) of 17.84% and significant growth in profit before tax and profit after tax compared to previous quarters. Additionally, institutional investors have increased their stake, indicating growing confidence in the company's fundamentals.
In the broader market context, while Aarti Drugs has seen a recent uptick in price, it has still lagged behind the benchmark Sensex, which has gained 0.58% over the past week. The stock's year-to-date performance shows a decline of 5.05%, contrasting with the Sensex's increase of 5.01%. This disparity highlights the challenges Aarti Drugs faces in regaining investor confidence despite its recent price rise. The falling investor participation, as indicated by a significant drop in delivery volume, suggests that while there may be short-term gains, long-term sentiment remains cautious, particularly in light of the stock's overall negative returns over the past year.